Evercore ISI Group Downgrades Inspire Medical Systems to In-Line, Lowers Price Target to $40
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. INSP | 0.00 |
Evercore ISI Group analyst Daniel Markowitz downgrades Inspire Medical Systems (NYSE:
INSP) from Outperform to In-Line and lowers the price target from $55 to $40.